These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 7315512)

  • 41. Panel: "present use of blood and blood products.".
    Sheldon GF; Watkins GM; Glover JL; Greenburg AG; Friedman BA
    J Trauma; 1981 Dec; 21(12):1005-12. PubMed ID: 7321062
    [No Abstract]   [Full Text] [Related]  

  • 42. [Recommendations for the prevention and treatment of transfusion reactions].
    Blut; 1976 Feb; 32(2):131-6. PubMed ID: 1247701
    [No Abstract]   [Full Text] [Related]  

  • 43. [Modezhel' erythrocyte preservative as an experimental and clinical blood substitute].
    Selivanov EA; Mel'nikova VN; Kochetygov NI; Pleshakov VT; Gerbut KA; Krivtsova IM; Lur'e GO
    Vestn Khir Im I I Grek; 1996; (1):71-4. PubMed ID: 8753967
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The effectiveness of augmented acute normovolemic hemodilution (A-ANH)].
    Spahn DR; Willimann PF; Faithfull NS
    Anaesthesist; 2001 Jan; 50 Suppl 1():S49-54. PubMed ID: 11271361
    [No Abstract]   [Full Text] [Related]  

  • 45. Jehovah's Witnesses and blood transfusion revisited: a review of the benefits and risks.
    Orji EO; Sotiloye D; Fawole AO; Huyinbo KI
    Niger J Med; 2001; 10(2):55-8. PubMed ID: 11705058
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of severe anaemia with perfluorocarbon blood substitutes: a clinical overview.
    Nyberg SL; Cerra FB
    Clin Intensive Care; 1991; 2(4):226-32. PubMed ID: 10149096
    [No Abstract]   [Full Text] [Related]  

  • 47. [Letter: Whole blood transfusion of erythrocyte concentrate?].
    Lefévre H
    Dtsch Med Wochenschr; 1974 Jan; 99(3):113. PubMed ID: 4812782
    [No Abstract]   [Full Text] [Related]  

  • 48. [Clinical observations on the prophylaxis and treatment of postoperative shock by transfusions of different quantities of blood and blood substitutes].
    REKWART S; ROEFLER W
    Pol Tyg Lek (Wars); 1957 Apr; 12(14):506-10. PubMed ID: 13452943
    [No Abstract]   [Full Text] [Related]  

  • 49. [The demand for blood transfusion agents and blood substitutes in the treatment of wounded patients].
    Zhiburt EB; Danil'chenko VV; Popova NN; Vil'ianinov VN
    Voen Med Zh; 1999 Sep; 320(9):46-51, 96. PubMed ID: 10575950
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Biophysical studies of blood products within the scope of the development of a blood component therapy program for surgical practice].
    Wilms K; Lange G; Vogel R; Wulf K
    Anaesthesiol Reanim; 1986; 11(6):319-30. PubMed ID: 3814306
    [No Abstract]   [Full Text] [Related]  

  • 51. [Transfusion of blood and plasma substitutes; risks, value and limitation].
    REISSIGL H
    Chirurg; 1954 Dec; 25(12):529-32. PubMed ID: 14352366
    [No Abstract]   [Full Text] [Related]  

  • 52. Component therapy of surgical hemorrhage: red cells, plasma substitutes and albumin.
    Lundsgaard-Hansen P; Pappova E
    Ann Clin Res; 1981; 13 Suppl 33():26-38. PubMed ID: 7342841
    [No Abstract]   [Full Text] [Related]  

  • 53. [Blood and its substitutes in the complex therapy of infectious hepatitis].
    Ivanov FK
    Vrach Delo; 1967; 9():105-7. PubMed ID: 5621763
    [No Abstract]   [Full Text] [Related]  

  • 54. [On acute renal insufficiency in patients with severe multiple injuries and on the dangers of massive transfusions of preserved blood].
    Matossi L'Orsa R; Boaro G
    Minerva Anestesiol; 1967 Jan; 33(1):36-8. PubMed ID: 5596006
    [No Abstract]   [Full Text] [Related]  

  • 55. [Methodological aspects of the problems of blood substitutes].
    Rozenberg GIa; Shlimak VM
    Probl Gematol Pereliv Krovi; 1980 Sep; 25(9):3-8. PubMed ID: 7422641
    [No Abstract]   [Full Text] [Related]  

  • 56. [The rapid transfusion of large amounts of blood, blood derivatives and blood substitutes in massive intraoperational hemorrhage (author's transl)].
    Antoszewski Z; Tokarz S; Zelawska M
    Przegl Lek; 1978; 35(3):387-9. PubMed ID: 653011
    [No Abstract]   [Full Text] [Related]  

  • 57. [Effect of blood transfusion and protein hydrolysates on the blood proteins in patients with suppurative lung diseases].
    Veselova TA
    Vestn Khir Im I I Grek; 1965 Mar; 94(3):70-3. PubMed ID: 5865293
    [No Abstract]   [Full Text] [Related]  

  • 58. Prospectus. Future trends in transfusion.
    Manner PA; Rubash HE; Herndon JH
    Clin Orthop Relat Res; 1998 Dec; (357):101-15. PubMed ID: 9917706
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Problems of development, production and clinical use of highly effective blood substitutes].
    Merzlov VP; Khliabich KG; Chernenko GT
    Vestn Khir Im I I Grek; 1999; 158(4):65-7. PubMed ID: 10533227
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Introduction to the treatment of hemorrhagic syndromes by transfusion of blood or its derivatives].
    SOULIER JP
    Rev Pathol Gen Physiol Clin; 1954 Feb; 54(655):277-81. PubMed ID: 13167975
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.